Would Liability Proposal Boost EU Medtech Firms At Expense Of Non-EU Players?
This article was originally published in Clinica
Executive Summary
As a ploy designed to tilt the balance of power to manufacturers based in the EU and discourage their non-EU rivals from entering this market, the Council of the EU’s proposal to make authorized representatives liable for defective devices manufactured by non-EU companies might be very effective.